CON-POJoint Pulmonologist and ENT Consultation for Asthma and Chronic Rhinosinusitis with Nasal Polyposis
Joint consultation
+ Mucus sampling
+ Nasal brushing
Asthma+6
+ Bronchial Diseases
+ Hypersensitivity
Other Study
Summary
Study start date: November 1, 2025
Actual date on which the first participant was enrolled.This study focuses on improving the care for patients suffering from both asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). These conditions often occur together as they affect different parts of the same respiratory system. The study explores whether a joint consultation involving both a lung specialist (pulmonologist) and an ear, nose, and throat (ENT) specialist can provide better treatment outcomes compared to seeing these specialists separately. The aim is to see if this combined approach reduces the need for oral corticosteroids, which are often used to manage these conditions. Successful results could mean more effective and personalized care for patients, and possibly even introduce a more efficient healthcare model. Participants in this study will be divided into two groups. One group will receive joint consultations from both a pulmonologist and an ENT specialist, while the other group will continue with the usual separate consultations. The effectiveness of these consultations will be measured by tracking the need for oral corticosteroids over the following year. Additionally, the study will assess other factors such as the frequency of asthma attacks, ENT-related incidents, respiratory symptoms, quality of life, and overall use of healthcare resources. This comprehensive evaluation will help determine if the joint consultation model can offer significant benefits over traditional methods.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.195 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives